Our Services

 

Mutual Fund Distribution

Mutual Funds have emerged as a biggest and most sought-after investment option in modern times. But with so many funds and schemes in the market, it has become mind-boggling to choose the right fund/scheme. Having invested in mutual funds, there is another more herculean task of managing the funds, knowing their folios and current NAV. We will help you in evaluating the correct fund/scheme suitable to you based on your risk-bearing appetite and also help you in knowing the current NAVs and managing your folios across different funds/schemes.

Life Insurance Planning

Two major risks of Life - Living too long and living too short needs to be taken care of. We have wide range of Insurance Options to take care of both the events. Whats more! Life Insurance planning can help you achieve your financial goals and save on your taxes too. Remember - There is no substitute to Life Insurance. We will help you in structuring your insurance planning based on your needs and requirements.

Health Insurance Planning

Medical expenses are rising day by day and are only expected to go further up! Health insurance serves as hedge against medical expenses. We have good health insurance policies to cater to your needs.

General Insurance Planning

We at Insurance Services India deals in all the General Insurance Products across various General Insurance Cos. as per our customer’s need and convenience.


Equity/Share Advisory Services

Investing in stock market is inarguably the best route to create wealth in long-term. However, it can also be a very risky proposition due to high risk-return trade-off prevalent in the stock market. Hence, it is more appropriate to take help of an experienced and trustworthy expert who will guide you as to when, where and how to invest.

Insurance Services India provides guidance in the exciting world of stock market with suitable trading solutions and value-added tools and services to enhance your trading experience


Regular investing in MF schemes reached a new milestone, with SIP accounts crossing 4 crore and SIP AUM reaching an all-time high of Rs 483,964 crore
Fri, 09 Jul 2021 12:12:17 +0530


The company will separately announce price band and lot size for its IPO in coming few days. The issue will close on August 6.
Wed, 28 Jul 2021 18:55:01 +0530


The price band for the offer could be disclosed separately by the company in coming days. The issue will close on August 6.
Wed, 28 Jul 2021 13:12:35 +0530


Arihant Capital has come out with its report on Rolex Rings. The research firm has recommended to #39;#39;Subscribe#39;#39; the ipo in its research report as on July 27, 2021.
Wed, 28 Jul 2021 12:29:56 +0530


KR Choksey has come out with its report on Rolex Rings. The research firm has recommended to #39;#39;Subscribe#39;#39; the ipo in its research report as on July 28, 2021.
Wed, 28 Jul 2021 12:23:59 +0530


Considering the business growth outlook and almost stable operating margins, Choice Broking assigned a #39;subscribe#39; rating to the issue.
Wed, 28 Jul 2021 11:42:58 +0530


Rolex Rings IPO: At the upper band of IPO price of Rs 900, it is valued at a P/E multiple of 35 (on recalculated EPS excluding the Rs 25 crore deferred tax credit) which is lower than the industry average of 83, said KR Choksey Research.
Wed, 28 Jul 2021 11:27:06 +0530


Rolex Rings IPO: At higher price band of Rs 900, Rolex Rings is demanding a price-to-earnings (P/E) valuation of 28.2x (to its restated FY21 EPS of Rs 31.9) with a market cap of Rs 2,451 crore, while its peers namely Ramkrishna Forgings and MM Forgings are trading at a P/E of 123.30 and 37.14, respectively
Wed, 28 Jul 2021 08:57:45 +0530


Marquee investors participated in the anchor book were Invesco Mutual Fund, Matthews Asia Funds, and HSBC Global Investment Funds.
Tue, 27 Jul 2021 20:21:21 +0530


The public issue will be open for subscription between July 28-30.
Tue, 27 Jul 2021 15:45:53 +0530


Geojit has come out with its report on Glenmark Life Sciences. The research firm has recommended to #39;#39;Subscribe#39;#39; the ipo in its research report as on July 24, 2021.
Tue, 27 Jul 2021 13:43:51 +0530


Ajcon Global has come out with its report on Glenmark Life Sciences. The research firm has recommended to #39;#39;Subscribe#39;#39; the ipo in its research report as on July 26, 2021.
Tue, 27 Jul 2021 13:38:08 +0530


Arihant Capital has come out with its report on Glenmark Life Sciences. The research firm has recommended to #39;#39;Subscribe#39;#39; the ipo in its research report as on July 26, 2021.
Tue, 27 Jul 2021 13:30:59 +0530


Choice Equity Broking has come out with its report on Glenmark Life Sciences. The research firm has recommended to #39;#39;Subscribe#39;#39; the ipo in its research report as on July 23, 2021.
Tue, 27 Jul 2021 13:24:19 +0530


The subsidiary of Glenmark Pharma plans to raise Rs 1,513.6 crore through the public issue which comprises a fresh issue of Rs 1,060 crore, and an offer for sale of 63 lakh equity shares by promoter.
Tue, 27 Jul 2021 11:27:19 +0530


Glenmark Life Sciences IPO: The company has debt-to-equity of 1.3x with a debt of Rs 916 crore which includes Rs 800 crore payable to Glenmark Pharmaceuticals, post-IPO debt will be negligible.
Tue, 27 Jul 2021 09:26:50 +0530

Video Box